Aquatic Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Aquatic Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,900	Closed	-$171K	–	1676
2024 Q1	$171K	Sell	10,900 -1,100	-9%	-$16.9K	0.01%	801
2023 Q4	$194K	Buy	12,000 +11,500	+2,300%	+$147K	0.01%	857
2023 Q3	$6K	Buy	+500	New	+$6.9K	﹤0.01%	1162
2022 Q4	–	Sell	-18,900	Closed	-$350K	–	1906
2022 Q3	$350K	Buy	+18,900	New	+$297K	0.03%	491

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Aquatic Capital Management's DCPH Position: Q2 2024 in Review

Aquatic Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 10,900 shares — an estimated $171K sold.

Aquatic Capital Management first reported a position in DCPH in Q3 2022 and held it in 4 quarters. The position peaked at $350K in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Aquatic Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Aquatic Capital Management sold 10,900 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $171K.
Aquatic Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Aquatic Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $350K in Q3 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.